Your browser doesn't support javascript.
loading
An Efficient Bivalent Cyclic RGD-PIK3CB siRNA Conjugate for Specific Targeted Therapy against Glioblastoma In Vitro and In Vivo.
Cen, Bohong; Wei, Yuanyi; Huang, Wen; Teng, Muzhou; He, Shuai; Li, Jianlong; Wang, Wei; He, Guolin; Bai, Xin; Liu, Xiaoxia; Yuan, Yawei; Pan, Xinghua; Ji, Aimin.
Afiliación
  • Cen B; Department of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, Guangdong, China; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, Guangdong, China; Department of Radiation Oncology, Affilia
  • Wei Y; Department of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, Guangdong, China.
  • Huang W; Department of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, Guangdong, China.
  • Teng M; Cancer Research Institute, Southern Medical University, Guangzhou 510515, China.
  • He S; Department of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, Guangdong, China.
  • Li J; Department of Orthopaedic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou 510515, Guangdong, China.
  • Wang W; Guangzhou RiboBio Co., Guangzhou 510663, Guangdong, China.
  • He G; Department of Hepatobiliary Surgery, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, Guangdong, China.
  • Bai X; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, Guangdong, China; Department of Orthopaedic Surgery, Nanfang Hospital of Southern Medical University, Guangzhou 510515, Guangdong, China.
  • Liu X; Department of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, Guangdong, China; Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510275, Guangdong, China.
  • Yuan Y; Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, Guangdong, China. Electronic address: yuanyawei2015@outlook.com.
  • Pan X; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou 510515, Guangdong, China; Guangdong Provincial Key Laboratory of Single Cell Technology and Application, Guangzhou 510515, Guangdong, China; Department of Genetics, Yale School
  • Ji A; Department of Pharmacy, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, Guangdong, China; Department of Radiation Oncology, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, Guangdong, China; Guangdong Provincial Key Laboratory of New D
Mol Ther Nucleic Acids ; 13: 220-232, 2018 Dec 07.
Article en En | MEDLINE | ID: mdl-30312846
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Nucleic Acids Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mol Ther Nucleic Acids Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos